TRXADE HEALTH INC - COM NEW (MEDS)

CUSIP: 89846A207

Q4 2020 13F Holders as of 31 Dec 2020

Share change
-424,514
SEC-reported price per share
$5.29
Number of holders
13
Value change
-$2,269,370
Number of buys
8
Number of sells
5

Security key

89846A207

Report period

Q4 2020

Institutions

13

Top holders

10

Ownership snapshot

Top reported holders of MEDS - TRXADE HEALTH INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
G2 Investment Partners Ma...
Disclosed value leader
G2 Investment Partners Ma...
Comparable rows
0/8
Latest evidence
30 Sep 2020
13F Highest disclosed value: $2,492,000 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

G2 Investment Partners Management LLC has the largest disclosed position value at $2.49M.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens G2 Investment Partners Management LLC's linked filing trail.
Disclosed position value Top 5
G2 Investment Partners Management... $2.49M
HEARTLAND ADVISORS INC $1.88M
ROYCE & ASSOCIATES LP $1.36M
PERRITT CAPITAL MANAGEMENT INC $744K
1492 Capital Management LLC $93K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
G2 Investment Partners Management LLC
13F
Company
13F
—
denominator unverified
$2,492,000
398,796 shares
— 30 Sep 2020
HEARTLAND ADVISORS INC
13F
Company
13F
—
denominator unverified
$1,875,000
300,000 shares
— 30 Sep 2020
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$1,363,000
218,000 shares
— 30 Sep 2020
PERRITT CAPITAL MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$744,000
119,095 shares
— 30 Sep 2020
1492 Capital Management LLC
13F
Company
13F
—
denominator unverified
$93,000
14,959 shares
— 30 Sep 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$65,000
10,426 shares
— 30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
13
Shares
637,880
Rows available
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
8
Q4 2020 holders
13
Holder diff
5
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .